| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.08 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |